DESCRIPTION
A 75-year-old male presented with exertional angina and breathlessness. The coronary angiogram showed disease affecting the left anterior descending and circumfl ex. Echocardiographic (echo) fi ndings were predominantly P2 prolapse ( video 1 ). On the three-dimensional (3D) echo there is obvious prolapse of the middle scallop of the posterior leafl et, no chordal rupture is seen; however, two rounded structure seen at the free edge of the posterior leaflet are indicative of chordal elongation ( video 2 ). He underwent coronary artery bypass grafting × 2 and mitral valve repair using Carpentier-Edwards physio II annuloplasty ring size 27 mm (Edward Life Sciences, Irvine, California, USA). Mitral valve repair involved quadrangular resection of the posterior leafl et ( fi gure 1 ) (myxomatous), repaired with prolene 5/0 (ethicon). Intraoperative echo showed mild residual mitral regurgitation (MR). Postoperative period was complicated by chest sepsis requiring prolonged ventilation. MR is defi ned as an abnormal reversal of blood fl ow from the left ventricle to the left atrium caused by disruption in any part of the mitral valve apparatus, which comprises the mitral annulus, the leafl ets, the chordae tendineae and the papillary muscles. The most common aetiologies of MR include mitral valve prolapse (MVP), rheumatic heart disease, infective endocarditis, annular calcifi cation, cardiomyopathy and ischaemic heart disease. Acute and chronic MR affect approximately 5 in 10 000 people.
Symptoms usually include dyspnoea, fatigue and orthopnoea resulting from impaired left ventricular function and pulmonary oedema.
3D echo using a transoesophageal approach is feasible and provides a detailed anatomic depiction of the mitral valve. This approach should be of value in the preoperative assessment of MVP, providing a complete visualisation of the valve before the intervention and possibly a better prediction of the feasibility of valve repair. 1 The three basic principles to achieve an effective mitral valve repair include preservation of leafl et mobility, restore a large surface of coaptation and remodelling the annulus. 2 If surgery is undertaken before onset of symptoms and where left ventricular function is preserved, the life expectancy should be similar to that of the general population. 3 The operative mortality for mitral valve surgery has steadily declined over the past decade, with the current mortality reported to the Society of Thoracic Surgery in the region of 1.5% for mitral valve repair and 5.5% for mitral valve replacement. 
